| BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809
|
US Biomax |
|
160.00€ |
|
Pub |
| PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010
|
US Biomax |
|
231.00€ |
|
Pub |
| BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231.00€ |
|
Pub |
| IC00011 |
Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
| BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160.00€ |
|
Pub |
| BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231.00€ |
|
Pub |
| BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160.00€ |
|
Pub |
| BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231.00€ |
|
Pub |
| T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953
|
US Biomax |
|
314.00€ |
|
Pub |
| BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
| BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
| BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
| BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160.00€ |
|
Pub |
| T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
| BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160.00€ |
|
Pub |
| CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b
|
US Biomax |
|
278.00€ |
|
Pub |
| BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
| BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246
|
US Biomax |
|
88.00€ |
|
Pub |
| BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722
|
US Biomax |
|
160.00€ |
|
Pub |
| PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
| BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231.00€ |
|
Pub |
| BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314.00€ |
|
Pub |
| BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456.00€ |
|
Pub |
| BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160.00€ |
|
Pub |
| BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160.00€ |
|
Pub |
| BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803
|
US Biomax |
|
231.00€ |
|
Pub |
| CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602
|
US Biomax |
|
231.00€ |
|
Pub |
| BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804
|
US Biomax |
|
160.00€ |
|
Pub |
| BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726
|
US Biomax |
|
231.00€ |
|
Pub |
| FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293.00€ |
|
Pub |
| PR804 |
Hyperplasia and carcinoma of prostate tissue array, 80 cases 80 cores, with grade and Gleason score information
|
US Biomax |
|
266.00€ |
|
Pub |
| BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726
|
US Biomax |
|
160.00€ |
|
Pub |
| BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160.00€ |
|
Pub |
| PR801 |
Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803
|
US Biomax |
|
231.00€ |
|
Pub |
| BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160.00€ |
|
Pub |
| ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278.00€ |
|
Pub |
| PR954 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955
|
US Biomax |
|
456.00€ |
|
Pub |
| BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804
|
US Biomax |
|
231.00€ |
|
Pub |
| BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160.00€ |
|
Pub |
| T194 |
Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
| BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160.00€ |
|
Pub |
| BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160.00€ |
|
Pub |
| BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456.00€ |
|
Pub |
| BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160.00€ |
|
Pub |
| PR953 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954
|
US Biomax |
|
456.00€ |
|
Pub |
| PR241 |
Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243
|
US Biomax |
|
88.00€ |
|
Pub |
| BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278.00€ |
|
Pub |
| BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
| LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| PR803 |
Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
| LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| PRC961 |
Prostate cancer tissue array, 48 cases 96 cores
|
US Biomax |
|
261.00€ |
|
Pub |
| ES801 |
Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010
|
US Biomax |
|
231.00€ |
|
Pub |
| OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456.00€ |
|
Pub |
| BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
| KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88.00€ |
|
Pub |
| MC962 |
Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| PR481 |
Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases 48 cores, with grades, stages and Gleason scores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T193 |
Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084
|
US Biomax |
|
88.00€ |
|
Pub |
| UT803 |
Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013
|
US Biomax |
|
231.00€ |
|
Pub |
| NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
| PR807 |
Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
| HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax |
|
160.00€ |
|
Pub |
| MC5001 |
High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002
|
US Biomax |
|
634.00€ |
|
Pub |
| PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805
|
US Biomax |
|
266.00€ |
|
Pub |
| SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801
|
US Biomax |
|
231.00€ |
|
Pub |
| BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014
|
US Biomax |
|
231.00€ |
|
Pub |
| CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
| BS04102 |
Large cell carcinoma of lung tissue array, 21 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231.00€ |
|
Pub |
| KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88.00€ |
|
Pub |
| ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004
|
US Biomax |
|
266.00€ |
|
Pub |
| PR752 |
Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| MC242 |
Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245
|
US Biomax |
|
88.00€ |
|
Pub |
| BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129
|
US Biomax |
|
189.00€ |
|
Pub |
| CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| NPC481 |
Nasopharyngeal carcinoma tissue array, 48 cases 49 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278.00€ |
|
Pub |
| BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278.00€ |
|
Pub |
| BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88.00€ |
|
Pub |
| LC2082 |
Multiple lung carcinoma and normal tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T381 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385
|
US Biomax |
|
88.00€ |
|
Pub |
| BS05041 |
Colon adenocarcinoma (grade III) tissue array, 23 cases 63 cores, replaced by CO725
|
US Biomax |
|
189.00€ |
|
Pub |
| BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814
|
US Biomax |
|
456.00€ |
|
Pub |
| BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231.00€ |
|
Pub |
| LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
| LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| PRC481 |
Prostate cancer tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| PE801 |
Penile (penis) carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC04013 |
Non small cell lung carcinoma tissue array, 63 cases 63 core, replaced by LC806
|
US Biomax |
|
160.00€ |
|
Pub |
| LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278.00€ |
|
Pub |
| FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax |
|
278.00€ |
|
Pub |
| ST802 |
Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964
|
US Biomax |
|
231.00€ |
|
Pub |
| PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
| BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
| PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
| BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702
|
US Biomax |
|
231.00€ |
|
Pub |
| T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085
|
US Biomax |
|
88.00€ |
|
Pub |
| UT802 |
Uteral cancer (multi types of uterine carcinomas and diseases) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
| BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| PR806 |
Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018
|
US Biomax |
|
160.00€ |
|
Pub |
| PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802
|
US Biomax |
|
231.00€ |
|
Pub |
| SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
| CO812 |
Colon carcinoma and normal tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax |
|
88.00€ |
|
Pub |
| LV721 |
Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC19111 |
Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| PR751 |
Prostate cancer, PIN (prostatic intraepithelial neoplasia) and hyperplasia tissue array, 75 cases 75 cores, with grade and Gleason's Score data
|
US Biomax |
|
266.00€ |
|
Pub |
| BS36011 |
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803
|
US Biomax |
|
266.00€ |
|
Pub |
| MC241 |
Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244
|
US Biomax |
|
88.00€ |
|
Pub |
| BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| LVC2281 |
Liver cancer high density tissue array, 228 cases 228 cores, replaced by LV2161
|
US Biomax |
|
403.00€ |
|
Pub |
| NPC111 |
Nasopharyngeal carcinoma tissue array, 11 cases 11 cores
|
US Biomax |
|
106.00€ |
|
Pub |
| BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962
|
US Biomax |
|
231.00€ |
|
Pub |
| CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189.00€ |
|
Pub |
| FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
| ME801 |
Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804
|
US Biomax |
|
231.00€ |
|
Pub |
| BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| MC541 |
Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542
|
US Biomax |
|
160.00€ |
|
Pub |
| OV804 |
Ovarian metastatic carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BO242 |
Human normal bone tissue array, 12 cases 24 cores, replaced by BO243
|
US Biomax |
|
100.00€ |
|
Pub |
| BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
| KD482 |
Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| LN801 |
Normal lymphatic (lymph node, thymus, spleen, tonsil and appendix) tissue array, 80 cases 80 cores, replaced by LN802
|
US Biomax |
|
231.00€ |
|
Pub |
| PR2085a |
High density (114 cases 208 cores) prostate adenocarcinoma (I 4 grade) and normal prostate (from autopsy and cancer adjacent) tissue array
|
US Biomax |
|
456.00€ |
|
Pub |
| BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b
|
US Biomax |
|
231.00€ |
|
Pub |
| BS05031 |
Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724
|
US Biomax |
|
160.00€ |
|
Pub |
| FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
| BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| PR8011 |
Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805
|
US Biomax |
|
314.00€ |
|
Pub |
| BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| LC805 |
Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
| OM601 |
Metastatic carcinoma of epiploon tissue array, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir
|
US Biomax |
|
487.00€ |
|
Pub |
| BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BS03013 |
Hepatocellular carcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
| FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
| ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336.00€ |
|
Pub |
| PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241
|
US Biomax |
|
88.00€ |
|
Pub |
| BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231.00€ |
|
Pub |
| BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
| BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724
|
US Biomax |
|
160.00€ |
|
Pub |
| MCN601 |
Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602
|
US Biomax |
|
231.00€ |
|
Pub |
| PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
| BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| T191 |
Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax |
|
231.00€ |
|
Pub |
| BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax |
|
160.00€ |
|
Pub |
| LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax |
|
231.00€ |
|
Pub |
| BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax |
|
231.00€ |
|
Pub |
| LV1501 |
Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| PR805 |
Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b
|
US Biomax |
|
278.00€ |
|
Pub |
| BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631
|
US Biomax |
|
160.00€ |
|
Pub |
| T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045
|
US Biomax |
|
88.00€ |
|
Pub |
| CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LV631 |
Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
| BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax |
|
88.00€ |
|
Pub |
| ME1001 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| PR721 |
Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804
|
US Biomax |
|
231.00€ |
|
Pub |
| T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
| LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax |
|
231.00€ |
|
Pub |
| BRC491 |
Human breast invasive ductal carcinoma (IDC) tissue array, non overlapping with BRC711, 49 cases 49 cores
|
US Biomax |
|
142.00€ |
|
Pub |
| T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
| LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231.00€ |
|
Pub |
| FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
| PR809 |
Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019
|
US Biomax |
|
266.00€ |
|
Pub |
| BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BS01042 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723
|
US Biomax |
|
160.00€ |
|
Pub |
| KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| PR208 |
High density (70 cases 208 cores), multiple prostate cancer (1 4 grade), normal prostate and placenta tissue array
|
US Biomax |
|
456.00€ |
|
Pub |
| BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BS05021 |
Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723
|
US Biomax |
|
160.00€ |
|
Pub |
| LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status
|
US Biomax |
|
160.00€ |
|
Pub |
| BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b
|
US Biomax |
|
160.00€ |
|
Pub |
| BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014
|
US Biomax |
|
160.00€ |
|
Pub |
| BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962
|
US Biomax |
|
0.00€ |
|
Pub |
| PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802
|
US Biomax |
|
266.00€ |
|
Pub |
| BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
| LC803 |
Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array
|
US Biomax |
|
231.00€ |
|
Pub |
| PR955 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954
|
US Biomax |
|
558.00€ |
|
Pub |
| BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| LC991 |
Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| OV1001 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005
|
US Biomax |
|
231.00€ |
|
Pub |
| KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386
|
US Biomax |
|
88.00€ |
|
Pub |
| PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
| BS06031 |
Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723
|
US Biomax |
|
160.00€ |
|
Pub |
| PR483 |
Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info
|
US Biomax |
|
160.00€ |
|
Pub |
| BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803
|
US Biomax |
|
231.00€ |
|
Pub |
| GL802 |
Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
| LC641 |
Non small cell lung carcinoma (NSCLC) tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
| BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803
|
US Biomax |
|
160.00€ |
|
Pub |
| LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722
|
US Biomax |
|
160.00€ |
|
Pub |
| LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information
|
US Biomax |
|
456.00€ |
|
Pub |
| BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804
|
US Biomax |
|
231.00€ |
|
Pub |
| IC03001 |
Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805
|
US Biomax |
|
231.00€ |
|
Pub |
| SM801 |
Small intestine carcinoma and normal tissue array, 77 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR805 |
Breast infiltrating lobular carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011
|
US Biomax |
|
231.00€ |
|
Pub |
| BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99.00€ |
|
Pub |
| PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| BR2001 |
Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086
|
US Biomax |
|
456.00€ |
|
Pub |
| BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
| T195 |
Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192
|
US Biomax |
|
113.00€ |
|
Pub |
| BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| LC1005 |
Lung carcinoma progression tissue array, 77 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
| FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
| PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012
|
US Biomax |
|
266.00€ |
|
Pub |
| BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
| CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| TMA2081 |
High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue
|
US Biomax |
|
456.00€ |
|
Pub |
| KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BR2085b |
High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast
|
US Biomax |
|
456.00€ |
|
Pub |
| LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
| PR207b |
High density prostate cancer (1 4 grade) and normal prostate tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC481 |
Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601
|
US Biomax |
|
231.00€ |
|
Pub |
| KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725
|
US Biomax |
|
160.00€ |
|
Pub |
| BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
| FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
| LV802 |
Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801
|
US Biomax |
|
189.00€ |
|
Pub |
| BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013
|
US Biomax |
|
231.00€ |
|
Pub |
| LC802 |
Lung small cell carcinoma tissue array (40 cases 80 cores)
|
US Biomax |
|
266.00€ |
|
Pub |
| NPC962 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC961, 96 cases 96 cores
|
US Biomax |
|
308.00€ |
|
Pub |
| CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2
|
US Biomax |
|
278.00€ |
|
Pub |
| GI481 |
GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
|
US Biomax |
|
231.00€ |
|
Pub |
| TP242 |
Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| PR242 |
Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| PR482 |
Multiple prostate cancer tissue array with 4 normal tissue control from autopsy, with TNM and Gleason Scores, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811
|
US Biomax |
|
231.00€ |
|
Pub |
| BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483
|
US Biomax |
|
160.00€ |
|
Pub |
| LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
| PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558.00€ |
|
Pub |
| ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516.00€ |
|
Pub |
| LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
| BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
| TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed
|
US Biomax |
|
742.35€ |
|
Pub |
| IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
| BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a
|
US Biomax |
|
88.00€ |
|
Pub |
| BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801
|
US Biomax |
|
160.00€ |
|
Pub |
| T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044
|
US Biomax |
|
88.00€ |
|
Pub |
| FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999
|
US Biomax |
|
314.00€ |
|
Pub |
| LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| MO32011 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replaced by MO1002
|
US Biomax |
|
189.00€ |
|
Pub |
| BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a
|
US Biomax |
|
88.00€ |
|
Pub |
| CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
| T391 |
Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392
|
US Biomax |
|
88.00€ |
|
Pub |
| LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| PA207 |
High density (69 cases 207 cores), multiple pancreatic cancer (1 3 grade) and normal pancreatic tissue array, replaced by PA2072
|
US Biomax |
|
456.00€ |
|
Pub |
| BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
| GL805 |
Glioblastoma multiforme (GBM) tissue array, 40 cases 80 cores, replaced by GL806
|
US Biomax |
|
266.00€ |
|
Pub |
| LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
| OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
| BS01032 |
Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808
|
US Biomax |
|
160.00€ |
|
Pub |
| BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266.00€ |
|
Pub |
| CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
| PR1001 |
Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
| BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| KD811 |
Renal carcinoma and normal tissue array, with TNM, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801
|
US Biomax |
|
160.00€ |
|
Pub |
| BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
| LV8013 |
Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
| PA241 |
Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b
|
US Biomax |
|
100.00€ |
|
Pub |
| PR753 |
Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases 75 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC801 |
Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| SK243 |
Age grouped female skin tissue array, 12 cases 24 cores, replaced by SK244
|
US Biomax |
|
231.00€ |
|
Pub |
| LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| NPC961 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC962, >50 cases 96 cores
|
US Biomax |
|
344.00€ |
|
Pub |
| LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
| TP241 |
Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM and pathology grade, 12 cases 24 cores
|
US Biomax |
|
99.00€ |
|
Pub |
| BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| T171 |
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases 24 cores, replaced by T174
|
US Biomax |
|
88.00€ |
|
Pub |
| SO8012 |
Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BS09011 |
Uteral leiomyoma (hysteromyoma) tissue array, 30 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| EMC1501 |
Endometrial cancer mid density tissue array, non overlapping with EMC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| GL722 |
Brain glioma (astrocytoma) tissue array, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC601 |
Non small cell lung carcinoma (NSCLC) and normal tissue array, 25 cases plus normal tissues, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
| OV2085 |
Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BN06012 |
Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| T071 |
Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| UT481 |
Endometrium cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| LV806 |
Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| BC35111 |
Retinoblastoma and normal adjacent tissue array, 17 cases 34 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info
|
US Biomax |
|
160.00€ |
|
Pub |
| STC2281 |
Stomach cancer high density tissue array, 228 cases 228 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| CO701 |
Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information
|
US Biomax |
|
231.00€ |
|
Pub |
| TET481 |
Human testis cancer tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
281.00€ |
|
Pub |
| LV1002 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ME2082 |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012
|
US Biomax |
|
231.00€ |
|
Pub |
| RE241 |
Rectal cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ST1003 |
Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| ES1921 |
Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| HN241 |
Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
| OV603 |
Ovarian serous cystadenoma tissue array, 30 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
| T092 |
Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| OR1001 |
Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BL241 |
Bladder cancer tissue array with self matching normal adjacent tissues, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231.00€ |
|
Pub |
| T007 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| CO807 |
Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| TH809 |
Thyroid cancer metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| KD2086 |
Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LV2086 |
Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| MG801 |
Meningioma of central nerve tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC10025 |
Cervical cancer and normal tissue array, 54 cases 54 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| RE812 |
Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20831 |
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T273 |
Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LM241 |
Multiple lymphoma tissue array with normal tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115
|
US Biomax |
|
0.00€ |
|
Pub |
| PIT501 |
Normal pituitary gland tissue array, 25 cases 50 cores
|
US Biomax |
|
261.00€ |
|
Pub |
| BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011
|
US Biomax |
|
278.00€ |
|
Pub |
| SM241 |
Small intestine adenocarcinoma tissue array (including normal adjacent tissue), 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| CXC961 |
Cervical cancer and normal tissue array, non overlapping with CXC962, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| GIST801 |
Gastrointestinal stromal tumor (GIST) tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LC2087 |
Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LY803 |
Lymphatic metastatic adenocarcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| OV1004 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BM241 |
Bone marrow tissue array, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T041 |
Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| COC482 |
Colon cancer and normal tissue array, non overlapping with COC481 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
| LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| MO30011 |
Mouse heart tissue array, 100 cases 100 cores, 50 male and 50 female
|
US Biomax |
|
160.00€ |
|
Pub |
| ST803 |
Stomach adenocarcinoma tissue array, in various type, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| CO242 |
Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
| T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| ESC1021 |
Esophagus cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| LP802 |
Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BC05022 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, no overlapping with BC05021
|
US Biomax |
|
231.00€ |
|
Pub |
| ST808 |
Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032
|
US Biomax |
|
231.00€ |
|
Pub |
| CO481 |
Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| T423 |
Small intestine cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| ESC481 |
Esophagus cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| LUC1502 |
Lung cancer mid density tissue array, non overlapping with LUC1501 or LUC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| PA1921 |
Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| RA162 |
Multiple organs normal tissue array of rat, 8 cases 16 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| SO806 |
Leiomyoma of uterus tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BS17017 |
Brain gliocytoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| EN801 |
Endocrine tumor tissue array, 40 cases 80 cores.
|
US Biomax |
|
266.00€ |
|
Pub |
| GL804 |
Brain tumor and normal tissue array with grade and TNM data, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071
|
US Biomax |
|
231.00€ |
|
Pub |
| OV2161 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
633.00€ |
|
Pub |
| BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001
|
US Biomax |
|
266.00€ |
|
Pub |
| SFD241 |
Human soft tissue disease tissue array, 24 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
| BRC1503 |
Breast cancer mid density tissue array, non overlapping with BRC1501 or BRC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax |
|
189.00€ |
|
Pub |
| FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401
|
US Biomax |
|
281.00€ |
|
Pub |
| LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| AC451 |
Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores
|
US Biomax |
|
331.00€ |
|
Pub |
| BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961
|
US Biomax |
|
266.00€ |
|
Pub |
| T0010 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031
|
US Biomax |
|
278.00€ |
|
Pub |
| TH721 |
Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LV1921 |
Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ME481 |
Multiple melanoma tissue array with normal skin tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| RE601 |
Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20821 |
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ST1921 |
Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T231 |
Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| ES241 |
Esophagus cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LC812 |
Lung cancer tissue array with normal tissues from autopsy, with TNM data, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013
|
US Biomax |
|
160.00€ |
|
Pub |
| BS01012 |
Stomach adenocarcinoma tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| T103 |
Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| CR805 |
Cervix cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| FRB281f |
Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores
|
US Biomax |
|
293.00€ |
|
Pub |
| LC20812 |
Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LY2082 |
Lymphoma survey tissue array (2 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| T013 |
Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| THY761 |
Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| KD242 |
Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| MNO961 |
35 types of normal human tissue array, 90 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| REC1502 |
Rectal cancer mid density tissue array, non overlapping with REC1501 or REC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| BR20836 |
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ST722 |
Stomach adenocarcinoma with self matched adjacent and normal tissue array, with stage and grade info, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T303 |
Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| ES803 |
Esophageal inflammation, hyperplasia and atypical hyperplasia tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LM801 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| MC802 |
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information
|
US Biomax |
|
266.00€ |
|
Pub |
| OVC241 |
Ovary cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
| SO208 |
Soft tissue sarcoma high density tissue array with normal controls, 69 cases 208 cores, with grade and stage data
|
US Biomax |
|
456.00€ |
|
Pub |
| T143 |
Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| DID381 |
Digestive system disease tissue array, 38 cases 38 cores
|
US Biomax |
|
166.00€ |
|
Pub |
| GL1921 |
Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| OV1921 |
Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BN00015 |
Multiple organ normal tissue array, 47 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
